Patent intelligence · CA
CA 2933552
ASSOCIATIONS DE PEPTIDES ET LEUR UTILISATION DANS LE TRAITEMENT DE L'ALLERGIE AUX ACARIENS
ASSOCIATIONS DE PEPTIDES ET LEUR UTILISATION DANS LE TRAITEMENT DE L'ALLERGIE AUX ACARIENS
Patent details — CA 2933552
- Jurisdiction
- CA
- Status
- granted
- Grant date
- Jul 2, 2015
- Expiration
- Jun 27, 2035
- Applicant
- ALK-ABELLO AS [DK]
- CPC classes
- A61K 39/ 35 A I, A61K/3935, A61P 37/ 08 A I, A61P/3708
Quick answer
CA 2933552 (ASSOCIATIONS DE PEPTIDES ET LEUR UTILISATION DANS LE TRAITEMENT DE L'ALLERGIE AUX ACARIENS) is held by ALK-ABELLO AS [DK]. Status: granted. Granted Jul 2, 2015. Expires Jun 27, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ALK-ABELLO AS [DK]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 39/ 35 A I, A61K/3935, A61P 37/ 08 A I, A61P/3708
More from ALK-ABELLO AS [DK]
Related pharmaceutical patents in our USPTO index.
-
WO 2024200854
ANTICORPS DE LIAISON AUX ALLERGÈNES APPROPRIÉS POUR TRAITER DES ALLERGIES AU POLLEN D'ARBRE
granted -
EP 4302751
ORALE DÜNNFILME MIT GERINGER WASSERAKTIVITÄT
granted -
EP 4302750
ORALE DÜNNFILME ENTHALTEND ADRENALIN
granted -
CA 3259886
DISPOSITIFS DE DÉPLACEMENT D'IGE-FCERI
granted -
WO 2023232958
INHIBITEURS DE LA KINASE DE BRUTON POUR LE TRAITEMENT D'UNE RÉACTION ALLERGIQUE SOUDAINE
granted -
CA 3255134
COMPOSITION D'ALLERGÈNE D'ARACHIDE
granted -
WO 2019224246
MÉTHODES FONDÉES SUR DES BIOMARQUEURS DESTINÉES AU TRAITEMENT D'UNE MALADIE ATOPIQUE PAR IMMUNOTHÉRAPIE
granted -
HK 1249412
PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF
granted
Frequently asked questions
What is US patent 2933552?
CA 2933552 (ASSOCIATIONS DE PEPTIDES ET LEUR UTILISATION DANS LE TRAITEMENT DE L'ALLERGIE AUX ACARIENS) is held by ALK-ABELLO AS [DK]. Status: granted. Granted Jul 2, 2015. Expires Jun 27, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns CA 2933552?
ALK-ABELLO AS [DK] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does CA 2933552 expire?
Our index shows an expiration date of Jun 27, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.